Therefore, our current finding that miR-128-3p could confer simultaneous suppression upon multiple inhibitors of β-catenin and TGF-β signalling has underscored the key roles of these miR-128-3p-targeted inhibitors in providing fine-tuned control of β-catenin and TGF-β signals in NSCLC. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.